Nayantara Coelho-Prabhu

Nayantara Coelho-Prabhu

Auto-generated profile, based on publicly available information

Nayantara Coelho-Prabhu

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2013 in BMJ Open
Verified
Journal Article
Open access
PDF file
NCNayantara Coelho-Prabhu
Nayantara Coelho-Prabhu
NSNilay D Shah
Nilay D Shah
HHHolly Van Houten
Holly Van Houten
PKPatrick S Kamath
Patrick S Kamath
TBTodd H Baron
Todd H Baron
Objective To determine utilisation of endoscopic retrograde cholangiopancreatography (ERCP); incidence of inpatient admissions for complications occurring within 30 days of ERCP and risk factors for procedural-related complications, in a population-based study. Design Retrospective cohort study. Setting Olmsted County, Minnesota. Participants All adult residents of Olmsted County, Minnesota, who underwent ERCP from 1997 to 2006. Interventions Diagnostic and therapeutic ERCPs were assessed. Primary and secondary outcome measures Patient and procedural characteristics and complications within 30 days; and rates of ERCP utilisation and unplanned admissions and risk factors for admissions. Results In 10 years, 1072 ERCPs were performed on 827 individual patients. Average utilisation of ERCP was 83.1 ERCPs/100 000 persons/year, with an increase from 58 to 104.8 ERCPs/100 000 persons/year over time, driven by increases in therapeutic procedures. Within 30 days after 236 procedures, 62 admissions were definitely related to the index ERCP. The complication rate was 5.3%, including pancreatitis (26, 2.4%), infection/cholangitis (16, 1.5%), bleeding (15, 1.4%) and perforation (4, 0.37%). 30-day mortality was 2.4%, none of which was directly related to the ERCP or complications thereof. Risk factors identified through multivariate analysis to be associated with adverse events included: age <45 years (p=0.0498); body mass index ≥35 (p=0.0024); pancreatic duct cannulation (p=0.0026); outpatient procedure (p<0.0001); intraprocedure sphincterotomy bleeding (p<0.0001); difficulty grade (p=0.115) and patient's first ERCP (p=0.0394). Limitations Retrospective study. Conclusions Population utilisation of ERCP rose during the study period, specifically in therapeutic procedures. Admissions within 30 days of ERCP are common but often unrelated. Complications of ERCP remain infrequent and deaths quite unusual.

26 April 2023 in iGIE
Verified
Journal Article
Open access
DVDaniela Guerrero Vinsard
Daniela Guerrero Vinsard
JFJeffrey R. Fetzer
Jeffrey R. Fetzer
UAUpasana Agrawal
Upasana Agrawal
JSJassimran Singh
Jassimran Singh
DDDevanshi N. Damani
Devanshi N. Damani
NCNayantara Coelho-Prabhu
Nayantara Coelho-Prabhu
Artificial intelligence has the potential to enhance the endoscopist’s ability to detect polypoid and nonpolypoid dysplasia, which could result in decreased rates of colorectal cancer in patients with inflammatory bowel disease (IBD). We aimed to develop the first known model for computer-aided detection (CADe) of colorectal lesions in patients with IBD. A CADe model developed at our institution with colorectal lesions from patients without IBD was tested for baseline performance in a dataset of high-definition white-light endoscopy (HDWLE) images of IBD-associated colorectal lesions. Subsequently, we retrained the original CADe to build an IBD-CADe model using 1266 HDWLE still images and 426 dye-based chromoendoscopy still images depicting histologically proven IBD-associated colorectal lesions. The lesions were annotated by histopathology, size, morphology, and inflammation score surrounding the lesion. We evaluated the model’s performance metrics before and after retraining. The sensitivity of the original CADe was 50%, positive predictive value (PPV) was 97%, and accuracy was 64%. With the retrained IBD-CADe model, performance metrics for detecting lesions on HDWLE were as follows: sensitivity, 95.1%; specificity, 98.8%; PPV, 98.9%; negative predictive value, 94.7%; accuracy, 96.8%; and area under the curve, .85. IBD-CADe for chromoendoscopy images showed a sensitivity of 67.4%, specificity of 88.0%, PPV of 83.3%, negative predictive value of 74.3%, accuracy of 77.8%, and area under the curve of .65. Subgroup analysis showed a 93% sensitivity for detecting lesions 5 mm or smaller, 91% for lesions 6 to 10 mm, and 85% for those larger than 10 mm. IBD-CADe performed best for Paris classification types Ip, Is, and IIa. Of 9 lesions missed by IBD-CADe, most had a Mayo endoscopic subscore of 0 or 1. This model is the first step toward developing other artificial intelligence–based endoscopic tools to enhance dysplasia detection for patients with IBD.

24 July 2019 in Endoscopy International Open
Verified
Journal Article
Open access
PDF file
SYSiddhant Yadav
Siddhant Yadav
ELEdward V. Loftus
Edward V. Loftus
WHW. Scott Harmsen
W. Scott Harmsen
LSLouis M. Wong Kee Song
Louis M. Wong Kee Song
NCNayantara Coelho-Prabhu
Nayantara Coelho-Prabhu
Background and study aims There are limited published data on endoscopic removal of colorectal polyps by endoscopic mucosal resection (EMR) and endoscopic mucosal dissection (ESD) in patients with inflammatory bowel disease (IBD). Patients and methods We performed a retrospective review of patients with colonic IBD and colonic polyps >10mm who underwent EMR and/or ESD at our institution between January 1, 2012 and June 31, 2016. Results Ninety-seven patients with pathology-confirmed IBD (median disease duration 16 years) were included. Mild or moderate active colitis (in background biopsies) was seen in 85 %. Of the total 124 polyps, location was ascending colon in 44 %, transverse in 15 % and sigmoid in 18.5 %; of the total, 55 % were < 20 mm and 45 % were ≥20mm in maximal diameter. Using the Paris classification, 56 % of polyps were polypoid sessile (Is) polyps, while 38 % were non-polypoid (IIa, IIb, IIc). EMR was used in 118 polyps, three required ESD, and three by combined EMR-ESD. Seventy-two percent were resected en-bloc; 28 % underwent piecemeal resection. Histology included low-grade dysplasia in 75, serrated adenoma in 31, and tubular adenoma in 14 polyps. Chromoendoscopy was used in 33 (26.6 %). Adverse events occurred in three patients. Colectomy was performed in 11 patients within 12 months. Recurrence was seen in 20 polyps, 11 of which were successfully resected en-bloc using EMR. Polyps ≥ 20 mm and polyps treated with APC were found to have a statistically significantly higher risk of recurrence. Conclusion This study demonstrates the efficacy and safety of endoscopic resection of large polyps in patients with IBD, making them effective alternatives to colectomy.

5 August 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SASatimai Aniwan
Satimai Aniwan
DBDavid H. Bruining
David H. Bruining
SPSang Hyoung Park
Sang Hyoung Park
BABadr F Al-Bawardy
Badr F Al-Bawardy
SKSunanda Kane
Sunanda Kane
ELEdward Loftus
Edward Loftus
Background and aims: Patient-reported outcomes (PROs) will become increasingly important as primary endpoints in future clinical trials. We aimed to evaluate the relationship between health-related quality of life (HRQoL) and the combination of patient-reported clinical symptoms (ClinPRO2) and Mayo endoscopic subscore (MES) in patients with ulcerative colitis (UC). Methods: We conducted a prospective cross-sectional study of 90 consecutive UC patients who were scheduled for sigmoidoscopy or colonoscopy. All patients completed the following questionnaires: (1) self-rated rectal bleeding and stool frequency (ClinPRO2); (2) Short Inflammatory Bowel Disease Questionnaire (SIBDQ); (3) European Quality of Life 5-Dimensions 3-Level (EQ5D3L); (4) Work Productivity and Activity Impairment questionnaire (WPAI); (5) Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F); and (6) Hospital Anxiety and Depression Scale (HADS). The endoscopic images were graded according to the MES. “No symptoms” was defined as a symptom score of 0, and “mucosal healing” was defined as MES score of 0–1. Correlations between the combined ClinPRO2 and MES with HRQoL were assessed using Spearman’s correlation coefficients. Results: The combination of the ClinPRO2 and MES was well correlated to SIBDQ (r = −0.70), EQ5D3L (r = −0.51), WPAI (r = 0.62), FACIT-F (r = −0.58), and HADS-depression (r = 0.45). SIBDQ scores had strong correlations with FACIT-F (r = 0.86), WPAI (r = −0.80), and HADS-depression (r = −0.75) (p < 0.05 for all correlations). Patients with no symptoms reported the greatest all HRQoL scores. Conclusions: In patients with ulcerative colitis, the combination of a ClinPRO2 and the MES had good correlation with the SIBDQ. In addition, SIBDQ was well correlated to the various HRQoL.

1 February 2023 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
PDF file
SUSiri A Urquhart
Siri A Urquhart
BCBryce P Comstock
Bryce P Comstock
MJMauricio F Jin
Mauricio F Jin
CDCourtney N Day
Courtney N Day
JEJohn E Eaton
John E Eaton
NCNayantara Coelho-Prabhu
Nayantara Coelho-Prabhu
Background: Ileal pouch–anal anastomosis (IPAA) is the standard restorative procedure following proctocolectomy in patients with inflammatory bowel disease (IBD) who require colectomy. However, removal of the diseased colon does not eliminate the risk of pouch neoplasia. We aimed to assess the incidence of pouch neoplasia in IBD patients following IPAA. Methods: All patients at a large tertiary center with International Classification of Diseases–Ninth Revision/International Classification of Diseases–Tenth Revision codes for IBD who underwent IPAA and had subsequent pouchoscopy were identified using a clinical notes search from January 1981 to February 2020. Relevant demographic, clinical, endoscopic, and histologic data were abstracted. Results: In total, 1319 patients were included (43.9% women). Most had ulcerative colitis (95.2%). Out of 1319 patients, 10 (0.8%) developed neoplasia following IPAA. Neoplasia of the pouch was seen in 4 cases with neoplasia of the cuff or rectum seen in 5 cases. One patient had neoplasia of the prepouch, pouch, and cuff. Types of neoplasia included low-grade dysplasia (n = 7), high-grade dysplasia (n = 1), colorectal cancer (n = 1), and mucosa-associated lymphoid tissue lymphoma (n = 1). Presence of extensive colitis, primary sclerosing cholangitis, backwash ileitis, and rectal dysplasia at the time of IPAA were significantly associated with increased risk of pouch neoplasia. Conclusions: The incidence of pouch neoplasia in IBD patients who have undergone IPAA is relatively low. Extensive colitis, primary sclerosing cholangitis, and backwash ileitis prior to IPAA and rectal dysplasia at the time of IPAA raise the risk of pouch neoplasia significantly. A limited surveillance program might be appropriate for patients with IPAA even with a history of colorectal neoplasia.

23 June 2025 in Therapeutic Advances in Gastroenterology
Verified
Journal Article
Open access
SUSiri A. Urquhart
Siri A. Urquhart
MCMichael Christof
Michael Christof
NCNayantara Coelho-Prabhu
Nayantara Coelho-Prabhu
Inflammatory bowel disease (IBD) is a group of chronic inflammatory conditions of the gastrointestinal tract resulting from an inappropriate immune response to an altered gut microbiome in genetically predisposed individuals. Endoscopy plays a central role in IBD management, aiding in diagnosis, disease staging, monitoring, and therapeutic guidance. Patients with IBD face an increased risk of colorectal neoplasia due to chronic inflammation. Artificial intelligence (AI)-based systems show promise in detecting and classifying dysplasia and neoplasia during endoscopic evaluation. While there have been several studies on the application of AI to detect and diagnose various types of neoplasia in the non-IBD population, the literature in patients with IBD is limited. We aim to summarize the current evidence on the application of AI technologies to detect IBD-associated neoplasia, highlighting potential benefits, limitations, and future directions. A comprehensive literature search was performed using the PubMed database to identify relevant studies from January 2010 to February 2025. Additional references were identified from the relevant articles’ bibliographies. AI-assisted endoscopy, particularly using machine learning and deep learning techniques, has shown promise in improving lesion detection rates and supporting real-time decision-making. Computer-aided detection systems may increase the sensitivity of dysplasia identification, while computer-aided diagnosis tools can aid in lesion characterization. Early studies suggest that AI can reduce interobserver variability, improve targeting of biopsies, and potentially lead to more personalized surveillance strategies. Although clinical data specific to IBD-related neoplasia remain limited compared to sporadic colorectal neoplasia, the integration of AI into endoscopic practice holds significant potential to enhance dysplasia detection and improve patient outcomes. Continued research, validation in IBD-specific cohorts, and integration with clinical workflows are essential to realize the full impact of AI in this setting.